News & Updates

Learn about a collaboration between NICHD and Howard University.

NICHD researchers conducting a clinical study of patients with a rare, fatal neurological disorder have partnered with basic scientists to find better ways to understand the disease, monitor its progression, and ultimately find treatments.

A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The increase was not associated with any change in the number of days of menses (days of bleeding). Funded by the National Institutes of Health, the new study included data from nearly 20,000 people from Canada, the United Kingdom, the United States, Europe and other parts of the world who received any of nine different vaccines. For most study participants, the increase resolved in the cycle following vaccination.

Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a study funded by the National Institutes of Health. Antenatal steroid therapy, given to women at risk of preterm delivery, causes the fetal lungs to mature and has been shown to improve survival and reduce complications among infants born from 24 to 34 weeks of pregnancy. However, previous studies of the treatment for infants born between the 22nd and 23rd week—those at greatest risk for death and disability—were inconclusive.

Psychological distress before COVID-19 infection—feeling stressed, depressed, anxious, worried, or lonely—may raise the risk for long COVID, suggests a study funded by the National Institutes of Health.

Eight years ago, NIH announced a collaboration with the Bill & Melinda Gates Foundation to develop solutions for a variety of global health challenges. Learn how NICHD research is supporting this goal.

U.S. rates of pregnancy-associated homicide—deaths that occur among women who are pregnant or had been pregnant within one year—rose in 2020 during the COVID-19 pandemic, according to a recent NICHD-funded study.

Challenge competitions offer a mechanism to quickly bring in diverse voices and expertise to innovate and problem-solve. This month, NICHD and partners launched two challenges focused on improving our nation’s maternal health: the RADx® Tech for Maternal Health Challenge and the Connecting the Community for Maternal Health Challenge.

The National Institutes of Health is offering up to $8 million in cash prizes to accelerate development of technologies to improve maternal health outcomes for those who live in areas lacking access to maternity care.

The experimental drug TEMPOL prevents viral replication and reduces disease severity in a hamster model of COVID-19, according to a new study led by NICHD.

Patterns of gene expression—the degree to which genes are turned on or off—in uterine muscle tissue may help explain why fibroids disproportionately affect Black women, suggests a study supported by NICHD. Understanding the factors that contribute to racial disparities in uterine fibroid disease can inform treatment and prevention approaches.

During a research career that spans four decades, NICHD’s Judith Kassis, Ph.D., has learned many lessons along the way. Learn about her story.

A treatment to move blood from the umbilical cord into an infant’s body may improve the overall health of newborns classified as non-vigorous—limp, pale and with minimal breathing, suggests a study funded by the National Institutes of Health. The procedure, known as umbilical cord milking, involves gently squeezing the cord between the thumb and forefinger and slowly pushing the blood into the abdomen.

The National Institutes of Health has awarded a total of $100 million over the next five years to support nine Autism Centers of Excellence (ACEs). This endeavor funds large research projects to understand and develop interventions for autism spectrum disorder (ASD). Created in 2007, the ACE program is renewed every five years.

Researchers funded by the National Institutes of Health have identified a protein that allows the uterus to stretch to accommodate a developing fetus. When the protein is deactivated, the uterus begins the contractions culminating in labor. The findings raise the possibility of preventing preterm labor by developing drugs to target the protein.

The National Institutes of Health has launched a $3 million challenge competition to encourage community-based and advocacy organizations in the United States to develop the infrastructure and capabilities necessary to conduct maternal health research.

Drug labels for diazepam and clindamycin now include better information for healthcare providers on recommended usage and dosage in pediatric populations.

The nine winning teams and five honorable mentions designed technology solutions to unmet health care needs.

Scientists funded in part by NICHD have generated a mouse embryo model, or embryoid, that develops beyond neurulation—formation of the neural tube, which gives rise to the central nervous system—and closely mirrors natural mouse embryos 8.5 days after fertilization. These embryoids offer a promising model system for research into factors affecting mammalian embryonic development and disease.

A multidimensional MRI method developed at NICHD can detect astrogliosis, a neuroinflammatory response that occurs in traumatic brain injury and many other neurological conditions, a new study suggests. Researchers had previously established that the multidimensional MRI strategy can identify diffuse axonal injury—a microscopic brain injury that, like astrogliosis, cannot be detected by conventional radiological methods.